Inertia For Supply Chain Change May Stick Even If BIOSECURE Fails

 
• By Sarah Karlin-Smith

Efforts to de-risk the pharma supply chain’s reliance on China likely will not completely disappear if the BIOSECURE proposal dies.

close up of Asia on world map
Pharma supply chains may continue diversifying their supply chains even without the BIOSECURE legislation. (Shutterstock)

More from Distribution/Supply Chain

More from Geography